BIOMAT Database Logo BIOMAT Database Logo

EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation. 1979

K Tanaka, and Y Harada, and M Katori

UI MeSH Term Description Entries
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Tanaka, and Y Harada, and M Katori
[Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
March 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Tanaka, and Y Harada, and M Katori
Decreased platelet aggregation but increased thromboxane A2 generation in polycythemia vera.
July 1985, Archives of internal medicine,
K Tanaka, and Y Harada, and M Katori
[Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
December 1978, Nihon rinsho. Japanese journal of clinical medicine,
K Tanaka, and Y Harada, and M Katori
Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
January 1980, Advances in prostaglandin and thromboxane research,
K Tanaka, and Y Harada, and M Katori
[Role of thromboxane A2 in platelet aggregation. Preliminary report].
January 1979, Rinsho byori. The Japanese journal of clinical pathology,
K Tanaka, and Y Harada, and M Katori
Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma.
January 1978, Pharmacological research communications,
K Tanaka, and Y Harada, and M Katori
Aspirin inhibits platelet aggregation but not because it prevents thromboxane synthesis.
October 1982, Lancet (London, England),
K Tanaka, and Y Harada, and M Katori
Mariannaepyrone--a new inhibitor of thromboxane A2 induced platelet aggregation.
January 2001, Zeitschrift fur Naturforschung. C, Journal of biosciences,
K Tanaka, and Y Harada, and M Katori
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
November 2008, Journal of thrombosis and haemostasis : JTH,
K Tanaka, and Y Harada, and M Katori
Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2.
October 1997, Thrombosis research,
Copied contents to your clipboard!